About Summit Biosciences
Summit Biosciences is a company based in Lexington (United States) founded in 2008 by Edwin Cohen was acquired by Kindeva Drug Delivery in January 2024. Summit Biosciences operates in a competitive market with competitors including Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, ApiJect and August Bioservices, among others.
- Headquarter Lexington, United States
- Founders Edwin Cohen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Kindeva Drug Delivery
(Jan 18, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Summit Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Summit Biosciences
Detailed funding history for Summit Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Summit Biosciences
Summit Biosciences has secured backing from 1 investor. Prominent investors backing the company include Kindeva Drug Delivery.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Injectables and biologics products are manufactured by the CDMO.
|
Locked | Locked | Locked |
Investor details for Summit Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Summit Biosciences
Investment portfolio details for Summit Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Summit Biosciences
Detailed financials for Summit Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Summit Biosciences Comparisons
Peer comparison for Summit Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Summit Biosciences
Summit Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, ApiJect and August Bioservices, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of pharmaceutical products
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
Diversified research services for clinical solutions are offered.
|
Detailed competitors of Summit Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Summit Biosciences
Complete news archive for Summit Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Summit Biosciences
Summit Biosciences was founded in 2008.
Summit Biosciences is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Edwin Cohen is the current CEO of Summit Biosciences. They have also founded this company.
Summit Biosciences was founded in 2008 in Lexington, United States, as a specialty pharmaceutical company. Generic and innovative nasal spray products are developed, manufactured, and commercialized by the firm. Contract development and manufacturing services are also provided to partners for various nasally delivered drugs and systems. The facility is FDA-approved, DEA-registered, and compliant with cGMP standards, supporting product development from concept through to commercialization.
Summit Biosciences's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
Summit Biosciences has 1 investor. Key investors include Kindeva Drug Delivery.